Literature DB >> 18337729

Unaffected patients with a homozygous absence of the SMN1 gene.

Maria Jedrzejowska1, Janina Borkowska, Janusz Zimowski, Anna Kostera-Pruszczyk, Michał Milewski, Marta Jurek, Danuta Sielska, Ewa Kostyk, Walenty Nyka, Jacek Zaremba, Irena Hausmanowa-Petrusewicz.   

Abstract

In this report, we present three families in which we identified asymptomatic carriers of a homozygous absence of the SMN1 gene. In the first family, the bialleleic deletion was found in three of four siblings: two affected brothers (SMA type 3a and 3b) and a 25-years-old asymptomatic sister. All of them have four SMN2 copies. In the second family, four of six siblings are affected (three suffer from SMA2 and one from SMA3a), each with three SMN2 copies. The clinically asymptomatic 47-year-old father has the biallelic deletion and four SMN2 copies. In the third family, the biallelic SMN1 absence was found in a girl affected with SMA1 and in her healthy 53-years-old father who had five SMN2 copies. Our findings as well as those of other authors show that an increased number of SMN2 copies in healthy carriers of the biallelic SMN1 deletion is an important SMA phenotype modifier, but probably not the only one.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337729     DOI: 10.1038/ejhg.2008.41

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  Genome-wide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity.

Authors:  Galina Y Zheleznyakova; Sarah Voisin; Anton V Kiselev; Markus Sällman Almén; Miguel J Xavier; Marianna A Maretina; Lyudmila I Tishchenko; Robert Fredriksson; Vladislav S Baranov; Helgi B Schiöth
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

2.  Therapy development in spinal muscular atrophy.

Authors:  Michael Sendtner
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

3.  Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype.

Authors:  Corey Ruhno; Vicki L McGovern; Matthew R Avenarius; Pamela J Snyder; Thomas W Prior; Flavia C Nery; Abdurrahman Muhtaseb; Jennifer S Roggenbuck; John T Kissel; Valeria A Sansone; Jennifer J Siranosian; Alec J Johnstone; Pann H Nwe; Ren Z Zhang; Kathryn J Swoboda; Arthur H M Burghes
Journal:  Hum Genet       Date:  2019-02-20       Impact factor: 4.132

4.  Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling.

Authors:  Steven F Dobrowolski; Ha T Pham; Frances Pouch Downes; Thomas W Prior; Edwin W Naylor; Kathy J Swoboda
Journal:  Clin Chem       Date:  2012-04-09       Impact factor: 8.327

Review 5.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

Review 6.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

7.  Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.

Authors:  Yi-Ning Su; Chia-Cheng Hung; Shin-Yu Lin; Fang-Yi Chen; Jimmy P S Chern; Chris Tsai; Tai-Sheng Chang; Chih-Chao Yang; Hung Li; Hong-Nerng Ho; Chien-Nan Lee
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

8.  Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III.

Authors:  Galina Yu Zheleznyakova; Anton V Kiselev; Viktor G Vakharlovsky; Mathias Rask-Andersen; Rohit Chavan; Anna A Egorova; Helgi B Schiöth; Vladislav S Baranov
Journal:  BMC Med Genet       Date:  2011-07-15       Impact factor: 2.103

9.  Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons.

Authors:  María G Boza-Morán; Rebeca Martínez-Hernández; Sara Bernal; Klaus Wanisch; Eva Also-Rallo; Anita Le Heron; Laura Alías; Cécile Denis; Mathilde Girard; Jiing-Kuan Yee; Eduardo F Tizzano; Rafael J Yáñez-Muñoz
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

Review 10.  In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.

Authors:  Kristine S Ojala; Emily J Reedich; Christine J DiDonato; Stephen D Meriney
Journal:  Brain Sci       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.